Life sciences

Revolutionizing treatments. Optimizing outcomes.

Technology is opening new possibilities for patient care and operational efficiency across the life sciences sector. Our expertise, insight and technological capabilities are helping companies take full advantage.

Female lab worker wearing purple gloves

Life sciences companies’ central role in drug pricing and access to medicines puts them on the frontline of societal challenges like aging populations, disease outbreaks, increasing incidence of cancer and cardiac disorders, and antibiotic resistance. Companies are also having to adapt to a dynamically changing clinical, regulatory, and business landscape. Creating the right solutions involves combining technology with innovative thinking and a data-driven strategy. That’s where CSEM is helping the industry meet the evolving needs of patients around the world.

High-impact biotechnology

Investment in technology is a priority across the healthcare sector. New biotechnologies are allowing clinicians to meet the needs of patients and their families more effectively. They are forming the basis of new medicines, diagnostics, and tissue-engineered products as well as gene and cell therapies.

TEER measurement for biological barriers.

We are using our expertise in miniaturization, integration, and microengineering to develop new devices, tools, and systems for toxicology, pharmacology, diagnostics, and regenerative medicine. They are providing enhanced performance as well as deepening our understanding of how our body is working and how it is affected by different drugs and chemicals.

A medical doctor using an optical pH sensor for wound monitoring on a patient's arm.

Precision engineered microtechnology and digitalization

CSEM technologies aim to improve the quality of life of patients and make new treatments accessible for all. Our technology platforms are addressing the evolving needs of the life sciences field using automated cell technologies, biomonitoring, and artificial intelligence.

From concept to prototyping and validation in biosafety level II laboratories, CSEM helps industry to innovate and develop new products across the following application domains:

·         Micro physiological systems and organoids

·         Point-of-care diagnostics

·         Labs of the future

Meet our happy customers

Logo IMT

Alexios Tzannis

Business Development Manager Life Sciences

CSEM was really open and flexible, proactively coming up with proposals for addressing the challenge and presenting the results superbly and on time—I can only give compliments about the collaboration.

Related Articles

Team picture with employees from Hamilton and from CSEM

21 November 2024

Hamilton’s liquid handling system unveils groundbreaking solution, powered by CSEM

CSEM and Hamilton have developed an innovative system to perform routine accuracy testing of automated liquid handling systems.

Two prototypes of “Active Aligners” equipped with antibacterial diffusers. The one on the left represents the transparent aligner prototype in its final appearance. The prototype on the right contains a blue liquid highlighting the innovation: a 3D-printed microchannel system.

19 September 2024

Dental innovation: Actival and CSEM launch 3D antibacterial aligners

Actival is redefining dental alignment with its innovative 'Active Aligners.' They feature patented 3D-printed microchannel technology developed by CSEM.

Hand holding the implantable biosensor CERES between finger and thumb: the size is similar to a 1cm tall match

25 July 2024

CSEM develops a pioneering implant to support reproductive medicine

Swiss-based start-ups Impli and Yalosys, and the technology innovation center CSEM present an implantable biosensor for real-time fertility hormone monitoring.